Acorda Therapeutics Inc (ACOR)
Delisted
7 May 2024
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 88
+0.08
+9.875%
$
12.42K Market Cap
6.61 P/E Ratio
- Div Yield
5,337 Volume
0 Eps
$ 0.8
Previous Close Investors:
Day Range
0.75 0.88
Year Range
0.25 4.13
Want to track ACOR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Acorda Therapeutics Inc Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| AG Anne Goffard Artal Group S.A. | 12,316.25 | $34.75M | $290,170.85 | -$34.46M | -99.17% |
